Pulsar Helium Provides Update on Transaction With Oscillate PLC
Rhea-AI Summary
Pulsar Helium (OTCQB: PSRHF) announced it has acquired 80% of Quantum Hydrogen from Oscillate PLC via an all‑share transaction after issuing five monthly tranches of Consideration Shares (each US$80,000) between Dec 18, 2025 and Mar 6, 2026.
The tranches reflected VWAPs from C$0.7543 to C$1.6581. Pulsar retains an option until May 3, 2027 to buy the remaining 20% for US$400,000 in five US$80,000 instalments. Consideration Shares carry a four‑month‑and‑one‑day hold period.
Positive
- Acquired 80% of Quantum Hydrogen through completed share tranches
- Option to acquire remaining 20% until May 3, 2027 for US$400,000
- Structured consideration: five completed monthly tranches of US$80,000
Negative
- Paid acquisition consideration using share issuances, creating shareholder dilution risk
- Potential further dilution if Pulsar issues US$400,000 of Consideration Shares to acquire 20%
News Market Reaction – PSRHF
On the day this news was published, PSRHF declined 7.76%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS
CASCAIS, Portugal, March 09, 2026 (GLOBE NEWSWIRE) -- Pulsar Helium Inc. (AIM: PLSR, TSXV: PLSR, OTCQB: PSRHF) (“Pulsar” or the “Company”), a primary helium company, provides an update following its announcements on November 4, 2025, December 19, 2025, January 21, 2026, and February 10, 2026, regarding its option to acquire up to
On December 18, 2025, the Company issued a total of 292,560 common shares (the “Consideration Shares”) to Oscillate, satisfying the first and second monthly share option tranches valued at US
On January 20, 2026, the Company issued an additional 145,434 Consideration Shares to Oscillate, satisfying the third monthly share option tranche of US
On February 9, 2026, the Company issued an additional 80,947 Consideration Shares to Oscillate, satisfying the fourth monthly share option tranche of US
On March 6, 2026, the Company issued an additional 66,022 Consideration Shares to Oscillate, satisfying the fifth and final monthly share option tranche of US
Under the terms of the agreement with Oscillate, the Company has now acquired
The Consideration Shares issued in connection with the Transaction are subject to a four-month-and-one-day hold period from the date of issuance.
On behalf of Pulsar Helium Inc.
“Thomas Abraham-James”
President, CEO and Director
Further Information:
Pulsar Helium Inc.
connect@pulsarhelium.com
+ 1 (218) 203-5301 (USA/Canada)
+44 (0) 2033 55 9889 (United Kingdom)
https://pulsarhelium.com
https://ca.linkedin.com/company/pulsar-helium-inc.
Strand Hanson Limited
(Nominated & Financial Adviser, and Broker)
Ritchie Balmer / Rob Patrick
+44 (0) 207 409 3494
Yellow Jersey PR Limited
(Financial PR)
Charles Goodwin / Annabelle Wills
+44 777 5194 357
pulsarhelium@yellowjerseypr.com
About Pulsar Helium Inc.
Pulsar Helium Inc. is a publicly traded company quoted on the AIM market of the London Stock Exchange (United Kingdom) and listed on the TSX Venture Exchange with the ticker PLSR (Canada), as well as on the OTCQB with the ticker PSRHF (United States of America). Pulsar's portfolio consists of its flagship Topaz helium project in Minnesota, USA, and the Tunu helium project in Greenland. Pulsar is the first mover in both locations with primary helium occurrences not associated with the production of hydrocarbons identified at each.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.